Evidence map›Paper›PMID 40450627›Full record

ArticleMycopathologia2025

Exopolysaccharides of Ganoderma lucidum Activate the NLRP3 Inflammasome, Modulating Phagocytes and the Response of Mice to Infection with Cryptococcus neoformans.

Pedro H M Bürgel, Raffael J A de Castro, Angelina M Basso, Luísa C Coelho, Clara L F Marina, Isaque M Siqueira, Alysia V Gonzales, Pavel Kucheryavy, Vitor H Pomin, Elaine Rosechrer Carbonero and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pedro H M Bürgel *Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Federal District, Brasília, 70910-000, Brazil.
Raffael J A de Castro *Laboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Federal District, Brasília, 70910-000, Brazil.
Angelina M BassoLaboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Federal District, Brasília, 70910-000, Brazil.
Luísa C CoelhoLaboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Federal District, Brasília, 70910-000, Brazil.
Clara L F MarinaLaboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Federal District, Brasília, 70910-000, Brazil.
Isaque M SiqueiraProgram of Molecular Pathology, Faculty of Medical Sciences, University of Brasília, Federal District, Brasília, 70910-000, Brazil.
Alysia V GonzalesPharmacognosy Division, Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS, 38677, USA.
Pavel KucheryavyNational Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS, 38677, USA.
Vitor H PominPharmacognosy Division, Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS, 38677, USA.
Elaine Rosechrer CarboneroSpecial Academic Unity of Chemistry, Federal University of Goiás, Catalão Campus, Catalão, Goias, 75704-020, Brazil.
Aldo H TavaresFaculty of Ceilândia, University of Brasília, Federal District, Brasília, 72220-275, Brazil.
Anamélia Lorenzetti BoccaLaboratory of Applied Immunology, Department of Cellular Biology, Institute of Biological Sciences, University of Brasília, Federal District, Brasília, 70910-000, Brazil. albocca@unb.br.ORCID http://orcid.org/0000-0003-3323-5300

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 305584/2023-5Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887507090/2020-00Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887705632/2022-00Fundação de Apoio à Pesquisa do Distrito Federal 00193-0000029/2019-53
6 · The paper itself

Abstract

Interleucin-1β (IL-1β) is a pivotal cytokine in pro-inflammatory response induction, and it is regarded as protective in various diseases. IL-1β secretion is mainly associated with activation of the inflammasome complex, which normally is tightly regulated, depending on two signals for significant activity. The water insoluble fraction of the mushroom Ganoderma lucidum was extracted and co-cultivated with murine bone-marrow macrophages. We demonstrated that G. lucidum exopolysaccharides (EPS) were able to induce IL-1β production and release in murine macrophages. The mechanisms underlying EPS-induced priming encompass recognition through dectin-1 and activation of the spleen tyrosine kinase (Syk)/nuclear factor kappa-light-chain-enhancer of the activated B (NF-kB) axis. In addition, EPS stimulates IL-1β secretion in a phagocytosis-dependent manner via the NLR family pyrin domain containing 3 (NLRP3) inflammasome activation in response to reactive oxygen species production, potassium efflux, phagolysosomal acidification, and cathepsin B release. Both caspase-1 and, to a lesser extent, caspase-8 were activated upon EPS stimulus and required for IL-1β cleavage and release. Lastly, EPS stimulated phagocytes' anticryptococcal activity in vitro, reducing intracellular fungal burden in dendritic cells. Moreover, oral treatment with EPS improved mice's survival in a cryptococcosis model. Our study highlighted significant stimulation by G. lucidum EPS to innate immune cells and improved its fungicidal activity, protecting the host in a murine model of infection, suggesting a potential adjuvant in antimicrobial treatment schemes.

Indexed as

CryptococcosisCryptococcus neoformansFungal PolysaccharidesInflammasomesMacrophagesNLR Family, Pyrin Domain-Containing 3 ProteinPhagocytesPolysaccharidesReishiAnimalsCells, CulturedDisease Models, AnimalInterleukin-1betaMiceMice, Inbred C57BLPhagocytosisFungal PolysaccharidesInflammasomesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mousePolysaccharidesCryptococcus neoformansGanodermaInflammasomeInnate immunityNLRP3Polysaccharides

Identifiers

PMID40450627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.